Results 21 to 30 of about 1,983,235 (163)
Comparison of histopathologic characteristics according to the dosage of anti-thymocyte globulin.
, 2023 Comparison of histopathologic characteristics according to the dosage of anti-thymocyte globulin.
Dong Hyun Kim (184121) +10 more
core +1 more source
Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia
Haematologica, 2011 Background A combination of horse anti-thymocyte globulin and cyclosporine produces responses in 60–70% of patients with severe aplastic anemia. We performed a phase II study of rabbit anti-thymocyte globulin and cyclosporine as first-line therapy for ...
Manuel G. Afable +12 more
doaj +1 more source
Haematologica, 2015 The impact of the intensity of graft-versus-host-disease immunoprophylaxis on transplantation outcomes in patients undergoing transplantation following reduced-intensity conditioning is unclear. This study addresses this issue in 228 adult patients above
Marie Thérèse Rubio +14 more
doaj +1 more source
Haematologica, 2017 Severe graft-versus-host disease is a major barrier for non-T-cell-depleted haploidentical stem cell transplantation. There is no consensus on the optimal graft-versus-host disease prophylaxis.
Annalisa Ruggeri +17 more
doaj +1 more source
Indian Journal of Transplantation, 2022 Introduction: The immunosuppressant regimen after kidney transplantation typically includes initial induction therapy followed by a maintenance regimen. The induction therapy was introduced with the aim of reducing acute rejections. A retrospective study
Datteswar Hota +6 more
doaj +1 more source
Current management of severe acquired aplastic anemia
Einstein (São Paulo), 2011 Overall survival in severe aplastic anemia has markedly improved in the past four decades due to advances in stem cell transplantation, immunosuppressive therapies and supportive care.
Phillip Scheinberg
doaj +2 more sources
Rabbit Allergy and Kidney Transplant: What’s the connection?
Graduate Medical Education Research Journal, 2023 Mentor: Scott Westphal Program: Internal Medicine Type: Case Report Background: An anti-thymocyte globulin (ATG, Thymoglobulin®) is a polyclonal, anti-human thymocyte antibody derived from rabbits, used for lymphocyte depleting induction ...
Debra Wekesa +2 more
doaj +1 more source
Frontiers in Pediatrics, 2022 Serotherapy comprising agents such as anti-thymocyte globulin, anti-T-lymphocyte globulin, and the anti-CD52 monoclonal antibody alemtuzumab is used widely to reduce the incidence of graft-versus-host disease (GvHD) after paediatric haematopoietic stem ...
Steven J. Keogh +3 more
doaj +1 more source
Haematologica, 2017 Allogeneic hematopoietic stem cell transplantation is increasingly used as treatment for patients with life-threatening blood diseases. Its curative potential is largely based on immune-mediated graft-versus-leukemia effects caused by donor T cells ...
Frédéric Baron +11 more
doaj +1 more source
Frontiers in Oncology, 2021 Objective: Haploidentical stem cell transplantation (haplo-SCT) has demonstrated encouraging results in younger patients. There is also an increasing need for haplo-SCT in older patients.
Yu-Qian Sun +32 more
doaj +1 more source